Similar articles for PMID: 28484945

Year	Number of Results
1980	1
1983	1
1988	1
1991	1
1992	2
1994	1
1995	1
1997	1
2006	3
2007	2
2008	1
2009	3
2010	3
2011	6
2012	24
2013	27
2014	20
2015	21
2016	27
2017	40
2018	39
2019	40
2020	45
2021	38
2022	35
2023	8
2024	0

1

The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.

Cho YH, Hwang JE, Chung HS, Kim MS, Hwang EC, Jung SI, Kang TW, Kwon DD, Choi SH, Kim HT, Kim TH, Kwon TG, Noh JH, Kim MK, Kim CS, Kang SG, Kang SH, Cheon J, Lee CH, Ku JY, Ha HK, Tae BS, Jeong CW, Ku JH, Kwak C, Kim HH. Cho YH, et al. Int Urol Nephrol. 2017 Aug;49(8):1383-1390. doi: 10.1007/s11255-017-1613-z. Epub 2017 May 8. Int Urol Nephrol. 2017. PMID: 28484945

2

Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy.

Mori K, Janisch F, Mostafaei H, Kimura S, Lysenko I, Karakiewicz PI, Briganti A, Enikeev DV, Rouprêt M, Margulis V, Chlosta P, Nyirady P, Babjuk M, Egawa S, Shariat SF. Mori K, et al. Urol Oncol. 2020 Jun;38(6):601.e17-601.e24. doi: 10.1016/j.urolonc.2020.02.008. Epub 2020 Feb 29. Urol Oncol. 2020. PMID: 32127252

3

Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy.

Ha YS, Kim SW, Chun SY, Chung JW, Choi SH, Lee JN, Kim BS, Kim HT, Yoo ES, Kwon TG, Kim WT, Kim WJ, Kim TH. Ha YS, et al. BMC Urol. 2019 Jan 24;19(1):10. doi: 10.1186/s12894-019-0439-7. BMC Urol. 2019. PMID: 30678673 Free PMC article.

4

De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy.

Nishikawa M, Miyake H, Fujisawa M. Nishikawa M, et al. Urol Oncol. 2016 Sep;34(9):417.e9-417.e15. doi: 10.1016/j.urolonc.2016.04.001. Epub 2016 May 11. Urol Oncol. 2016. PMID: 27180325

5

Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.

Kang M, Yu J, Sung HH, Jeon HG, Jeong BC, Park SH, Jeon SS, Lee HM, Choi HY, Seo SI. Kang M, et al. Int J Urol. 2018 Jun;25(6):596-603. doi: 10.1111/iju.13574. Epub 2018 May 13. Int J Urol. 2018. PMID: 29756394

6

The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.

Wang H, Fang K, Zhang J, Jiang Y, Wang G, Zhang H, Chen T, Shi X, Li Y, Duan F, Liu J. Wang H, et al. Int Urol Nephrol. 2017 Aug;49(8):1391-1398. doi: 10.1007/s11255-017-1618-7. Epub 2017 May 26. Int Urol Nephrol. 2017. PMID: 28550473

7

The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.

Gorgel SN, Kose O, Koc EM, Ates E, Akin Y, Yilmaz Y. Gorgel SN, et al. Int Urol Nephrol. 2017 Sep;49(9):1577-1583. doi: 10.1007/s11255-017-1648-1. Epub 2017 Jul 1. Int Urol Nephrol. 2017. PMID: 28669104

8

De Ritis Ratio (AST/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery.

Lee H, Choi YH, Sung HH, Han DH, Jeon HG, Chang Jeong B, Seo SI, Jeon SS, Lee HM, Choi HY. Lee H, et al. Clin Genitourin Cancer. 2017 Jun;15(3):e379-e385. doi: 10.1016/j.clgc.2016.08.023. Epub 2016 Sep 7. Clin Genitourin Cancer. 2017. PMID: 27692696

9

Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.

Xu H, Tan P, Ai J, Huang Y, Lin T, Yang L, Wei Q. Xu H, et al. Clin Genitourin Cancer. 2018 Oct;16(5):e1059-e1068. doi: 10.1016/j.clgc.2018.06.003. Epub 2018 Jun 14. Clin Genitourin Cancer. 2018. PMID: 29980449

10

De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.

Lee H, Lee SE, Byun SS, Kim HH, Kwak C, Hong SK. Lee H, et al. BJU Int. 2017 Feb;119(2):261-267. doi: 10.1111/bju.13545. Epub 2016 Jun 16. BJU Int. 2017. PMID: 27226065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

311 results

Results by year